Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Total Assets

Latest as of September 2025: CN¥14.37 Billion CNY ≈ $2.10 Billion USD

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) holds total assets worth CN¥14.37 Billion CNY (≈ $2.10 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Beijing Wantai Biological Pharmacy Enter book value and equity for net asset value and shareholders' equity analysis.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Total Assets Trend (2013–2024)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total assets have evolved over time, based on quarterly financial data.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total assets of CN¥14.37 Billion consist of 57.0% current assets and 43.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	16.3%
Accounts Receivable	CN¥2.08 Billion	14.1%
Inventory	CN¥863.19 Million	5.9%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥712.86 Million	4.9%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2013–2024)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing Wantai Biological Pharmacy Enter (603392) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Beijing Wantai Biological Pharmacy Enterprise Co Ltd's current assets represent 57.0% of total assets in 2024, a decrease from 59.9% in 2013.
Cash Position: Cash and equivalents constituted 16.3% of total assets in 2024, down from 22.0% in 2013.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 9.0% in 2013.
Asset Diversification: The largest asset category is accounts receivable at 14.1% of total assets.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Total Assets

Key competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Merus BV NASDAQ:MRUS	USA	$771.99 Million
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	China	CN¥7.26 Billion
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Beijing Hotgen Biotech Co Ltd SHG:688068	China	CN¥3.21 Billion
Savara Inc NASDAQ:SVRA	USA	$140.92 Million
Wuhan Hvsen Biotechnology Co Ltd SHE:300871	China	CN¥2.96 Billion
Wecome Pharmaceutical Co Ltd SHE:300878	China	CN¥1.49 Billion
Shanghai Shen Lian Biomedical Corp SHG:688098	China	CN¥1.56 Billion

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.26	4.61	2.39
Quick Ratio	3.82	4.18	1.90
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥6.12 Billion	CN¥7.04 Billion	CN¥1.15 Billion

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Wantai Biological Pharmacy Enterprise Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.20
Latest Market Cap to Assets Ratio	0.54
Asset Growth Rate (YoY)	-6.5%
Total Assets	CN¥14.69 Billion
Market Capitalization	$7.92 Billion USD

Valuation Analysis

Below Book Valuation: The market values Beijing Wantai Biological Pharmacy Enterprise Co Ltd's assets below their book value (0.54x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Beijing Wantai Biological Pharmacy Enterprise Co Ltd's assets decreased by 6.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)

The table below shows the annual total assets of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥14.69 Billion ≈ $2.15 Billion	-6.53%
2023-12-31	CN¥15.71 Billion ≈ $2.30 Billion	-3.17%
2022-12-31	CN¥16.23 Billion ≈ $2.37 Billion	+130.34%
2021-12-31	CN¥7.05 Billion ≈ $1.03 Billion	+101.10%
2020-12-31	CN¥3.50 Billion ≈ $512.70 Million	+61.84%
2019-12-31	CN¥2.16 Billion ≈ $316.80 Million	+19.30%
2018-12-31	CN¥1.81 Billion ≈ $265.54 Million	+9.60%
2017-12-31	CN¥1.66 Billion ≈ $242.29 Million	+13.84%
2016-12-31	CN¥1.45 Billion ≈ $212.83 Million	+32.03%
2015-12-31	CN¥1.10 Billion ≈ $161.20 Million	+36.76%
2014-12-31	CN¥805.50 Million ≈ $117.87 Million	+32.71%
2013-12-31	CN¥606.98 Million ≈ $88.82 Million	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$7.92 Billion

CN¥54.10 Billion CNY

Market Cap Rank

#2647 Global

#337 in China

Share Price

CN¥42.79

Change (1 day)

+5.21%

52-Week Range

CN¥37.95 - CN¥78.36

All Time High

CN¥142.90